Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1627824-09-2

Post Buying Request

1627824-09-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1627824-09-2 Usage

General Description

The chemical "(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate" is a compound consisting of isopropyl, phosphoryl, and amino functional groups. It is also composed of fluorine, carbon, and oxygen atoms, making it a fluorinated organic compound. The structure of this chemical suggests that it may have potential applications in materials science, pharmaceuticals, or as a building block in the synthesis of other complex molecules. The compound's specific stereochemistry, with the presence of both R and S chiral centers, could also make it of interest for medicinal chemistry purposes. Further investigation and testing would be necessary to determine the full potential and properties of this molecule.

Check Digit Verification of cas no

The CAS Registry Mumber 1627824-09-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,7,8,2 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1627824-09:
(9*1)+(8*6)+(7*2)+(6*7)+(5*8)+(4*2)+(3*4)+(2*0)+(1*9)=182
182 % 10 = 2
So 1627824-09-2 is a valid CAS Registry Number.

1627824-09-2Relevant articles and documents

Design, synthesis and evaluation of 2′-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents

Cao, Ruiyuan,Fan, Shiyong,Li, Song,Li, Wei,Li, Xiaoyuan,Li, Yuexiang,Yan, Linjie,Zhang, Hongjie,Zhong, Wu

supporting information, (2021/09/28)

A series of phosphoamidate derivatives of nucleoside 2′-acetylene-7-deaza-adenosine (NITD008) were synthesized and evaluated for their in vitro antiviral activities against the enteroviruses EV71 and EV-D68. The phosphoamidate (15f) containing a hexyl est

Prodrug compound and application ofprodrug compound in treatment of cancer

-

Paragraph 0170-0171, (2021/03/06)

The present invention provides a compound indicated by a formula (I), pharmaceutically acceptable salts or esters thereof, a pharmaceutical composition of the compound, and application of the compoundand the pharmaceutical composition in the inhibition or regulation of the activity of tyrosine kinase and treating disease symptoms or symptoms including cancer mediated by tyrosine kinase.

CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF

-

Paragraph 0327-0331, (2021/05/21)

An object of the present invention is to provide a compound exhibiting an excellent drug efficacy as an anti-adenoviral agent, and an anti-adenoviral agent. The present invention provides a compound represented by General Formula [1] (in the formula, R1 represents a halogen atom, an amino group which may be substituted, a C1-6 alkoxy group which may be substituted, a hydroxyl group which may be protected, or the like; R2 represents a hydrogen atom or an amino protecting group; R3 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like; R4 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like); or a salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1627824-09-2